share_log

We Think You Should Be Aware Of Some Concerning Factors In Zhongjin Irradiation's (SZSE:300962) Earnings

We Think You Should Be Aware Of Some Concerning Factors In Zhongjin Irradiation's (SZSE:300962) Earnings

我們認為您應該知道中金輻射(SZSE:300962)收益中一些令人擔憂的因素
Simply Wall St ·  2022/05/05 19:26

Zhongjin Irradiation Incorporated Company's (SZSE:300962) healthy profit numbers didn't contain any surprises for investors. We believe that shareholders have noticed some concerning factors beyond the statutory profit numbers.

中金輻射股份有限公司(SZSE:300962)健康的利潤數據不會給投資者帶來任何意外。我們相信,股東已經注意到了法定利潤數字以外的一些令人擔憂的因素。

See our latest analysis for Zhongjin Irradiation

請看我們對中金輻射的最新分析

SZSE:300962 Earnings and Revenue History May 5th 2022
深交所:300962財報及營收歷史2022年5月5日

The Impact Of Unusual Items On Profit

異常項目對利潤的影響

To properly understand Zhongjin Irradiation's profit results, we need to consider the CN¥8.5m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

要正確理解中金輻射的盈利業績,我們需要考慮歸因於異常項目的850萬元人民幣收益。雖然有更高的利潤總是好事,但不尋常的東西帶來的巨大貢獻有時會挫傷我們的熱情。我們對全球大多數上市公司進行了統計,不尋常的項目在性質上是一次性的,這是非常常見的。考慮到這個名字,這並不令人驚訝。假設這些不同尋常的項目在本年度不會再次出現,我們因此預計明年的利潤會更弱(也就是説,在沒有業務增長的情況下)。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Zhongjin Irradiation.

注:我們總是建議投資者檢查資產負債表的實力。點擊這裏可以看到我們資產負債表對中金輻射的分析。

Our Take On Zhongjin Irradiation's Profit Performance

我們對中金輻射的盈利表現的看法

Arguably, Zhongjin Irradiation's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Zhongjin Irradiation's statutory profits are better than its underlying earnings power. Nonetheless, it's still worth noting that its earnings per share have grown at 32% over the last three years. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Zhongjin Irradiation at this point in time. Case in point: We've spotted 2 warning signs for Zhongjin Irradiation you should be aware of.

可以説,中金輻射的法定收益被不尋常的提振利潤的項目扭曲了。正因為如此,我們認為可能是中金輻照的法定利潤好於其基礎盈利能力。儘管如此,值得注意的是,它的每股收益在過去三年裏以32%的速度增長。歸根結底,如果你想正確地瞭解這家公司,除了以上幾個因素之外,考慮其他因素也是至關重要的。因此,儘管盈利質量很重要,但考慮到中金輻射目前面臨的風險也同樣重要。舉個例子:我們發現了兩個中金輻射的警告信號,你應該注意。

This note has only looked at a single factor that sheds light on the nature of Zhongjin Irradiation's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只關注了一個因素,它揭示了中金輻射的利潤性質。但如果你有能力將注意力集中在細枝末節上,總會有更多的東西需要發現。一些人認為,高股本回報率是高質量企業的良好標誌。所以你可能想看看這個免費擁有高股本回報率的公司的集合,或內部人士正在購買的這份股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎?保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
這篇由《華爾街日報》撰寫的文章本質上是籠統的。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。簡單地説,華爾街在提到的任何股票中都沒有頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論